In our recent interview with Yamin 'Mo' Khan, CEO of hVIVO, we reflected on the company’s outstanding achievements in 2024 and gained insights into its ambitious roadmap for 2025. https://lnkd.in/eNmmyJPk #HVO
Vox Markets’ Post
More Relevant Posts
-
🔬🚀 Strategy Refined in MedTech 🚀🔬 A MedTech leader turned to Sedulo Group’s THINK, ACT, BEAT methodology when faced with new market competition. Discover how strategic simulation exercises fortified their commercial strategy. Ready to dive deeper? Explore our case study for the full story. https://lnkd.in/ebRXAwnF #MedTechInnovation #StrategicPlanning #CaseStudy
MedTech Company Enhances Strategy and Execution with Sedulo Group’s THINK, ACT, BEAT Methodology - Sedulo Group - Global Competitive Strategy
sedulogroup.com
To view or add a comment, sign in
-
A lot has changed in the 15 years since we started Nimbus, but our core mission of helping patients through groundbreaking #drugdiscovery has persisted. From challenging traditional pharma models to investing in cutting-edge technology, hear from our CEO Jeb Keiper and CBO Abbas Kazimi about how we’ve evolved while staying true to our patient-focused, science-first roots. Nimbuxtx.com #Nimbus15
To view or add a comment, sign in
-
A brilliant indepth sit down between David Wild, InVivo, the Citeline Commercial publication, and Erik Digman Wiklund, CEO, Circio Holding ASA , covering how Erik co-discovered #circularRNA, and how it has transformed into the modality that will replace #mRNA, and what this will do to the #RNA landscape. David looks into the whole scientific and commercial angle to work out how Circio can continue to crest the wave. https://lnkd.in/epMfeG4t
Circio’s Vision For Long-Lasting Nucleic Acid Therapeutics
insights.citeline.com
To view or add a comment, sign in
-
𝗔 𝗰𝗵𝗲𝗺𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗱𝗲𝘃𝗶𝗰𝗲 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗲𝗱 𝘁𝗵𝗮𝘁 𝗰𝗮𝗻 𝗺𝗮𝗶𝗻𝘁𝗮𝗶𝗻 𝘁𝗵𝗲 𝗱𝗼𝘀𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗱𝗿𝘂𝗴 𝗮𝘀 𝗻𝗲𝗲𝗱𝗲𝗱 𝘁𝗼 𝗯𝗼𝘁𝗵 𝗿𝗲𝗱𝘂𝗰𝗲 𝘁𝗼𝘅𝗶𝗰𝗶𝘁𝘆 𝗮𝗻𝗱 𝗸𝗶𝗹𝗹 𝘁𝗵𝗲 𝘁𝘂𝗺𝗼𝗿 𝗰𝗼𝗺𝗽𝗹𝗲𝘁𝗲𝗹𝘆. That is the second significant case of turning in vitro diagnostics into in vivo (the first was continuous glucose measurement). It seems that there will be many more. We'll come to a world where we are not monitoring tests but dealing with a continuous wearable device. Modern LIMS are not fully prepared for this. The data from the device in the described case is supposed to be used to calculate the drug dose, and this implies a very high responsibility: we have to apply online calibration. That is the responsibility of the producer who made the device, unlike laboratories with their independent control. It would be good to come up with something like LIMS for wearable continuous diagnostic devices - https://lnkd.in/ej5ZjS78 #MedicalTechnology #Chemotherapy #DrugDeliverySystems #CancerTreatment #MITresearch ##VivicaLIMS #LifeDataLab https://about.vivica.us https://lifedl.net
Vivica
about.vivica.us
To view or add a comment, sign in
-
I’m excited to announce ALTEN’s partnership with Kneat Solutions Services! 👏🏼 In the next three years, we will use Kneat’s digital validation platform, Kneat Gx, to enhance our validation processes and efficiency for clients in the #LifeSciences industry. This shift to #DigitalValidation will improve efficiency, ensure data integrity, and deliver high-quality solutions for patients. Learn more: https://lnkd.in/eKzKpUhV #ALTEN #Kneat #KneatGx
To view or add a comment, sign in
-
🚀 Exciting News and Throwback! 🚀 😊 In February 2024, VALAB, a leading player in France for the lab autoverification software, has been selected to participate in an acceleration program @FrenchHealthcare Booster Germany of Business France! ⭐ This incredible opportunity will allow us to immerse ourselves in one of Europe's most dynamic ecosystems, tapping into the vibrant innovation scene and leveraging the expertise of industry leaders and mentors. 🔎At VALAB, we're committed to driving meaningful change in the lab daily routine, and this program aligns perfectly with our vision. We're eager to collaborate with fellow innovators, explore new partnerships, and accelerate the development of groundbreaking solutions that 𝑤𝑖𝑙𝑙 𝑒𝑛ℎ𝑎𝑛𝑐𝑒 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 𝑖𝑛 𝑡ℎ𝑒 𝑝𝑜𝑠𝑡-𝑎𝑛𝑎𝑙𝑦𝑡𝑖𝑐𝑎𝑙 𝑝ℎ𝑎𝑠𝑒 𝑜𝑓 𝑚𝑒𝑑𝑖𝑐𝑎𝑙 𝑙𝑎𝑏𝑜𝑟𝑎𝑡𝑜𝑟𝑖𝑒𝑠. 🤝 Great meet up and inspiring discussions with: Guenther Illert (Healthcare Shapers), David Sainati, Cécilia Mesa, Daniel Schaffer (Akkreditierte Labore in der Medizin e.V (ALM)), Dr. Michael MÜLLER (MVZ Labor 28 GmbH), Daniela Kahlert (Roche), Jens Riedel (MELOS - Medizinische Labor-Organisations-Systeme GmbH) 🙏 A huge shoutout to Constant CHAUDIER whose hard work and dedication have made this possible. Together, we're poised to make a lasting impact on the healthcare landscape. Stay tuned for updates as we embark on this exciting journey! #HealthcareInnovation #AccelerationProgram #Germany #ExpertSystem #InnovateWithPurpose 🚀🏥💡
To view or add a comment, sign in
-
Kindeva delivers unrivaled expertise in respiratory drug delivery, backed by over 65 years of experience. In this video, Andy Burns, Vice President, MDI Business Development, covers our key innovations over the years and our future-forward initiatives. https://ow.ly/fXzS50T834E #Inhalation #Drugdelivery #CombineForces
To view or add a comment, sign in
-
Suvoda is proud to join Society for Clinical Research Sites (SCRS)’s Global Impact Partner (GIP) program to collaborate with research sites and industry partners, offering global expertise in alignment with the program’s mission. Our President and Chief Operating Officer, Robert Hummel, shares “As clinical trials increase in complexity and new technologies emerge, we are excited to work with SCRS and its member sites to transform the patient journey in a clinical trial. Our focus is on making our products more intuitive, robust, and streamlined so that site teams have the tools they need to calmly guide their patients through some of the most challenging moments of their lives.” Read more at https://lnkd.in/ewHYUaAB #Suvoda #clinicaltrials #clinicalresearch #healthtech
To view or add a comment, sign in
-
After nearly a decade contributing to the growth of anteris / Kymanox Europe, a leading professional services company in the medical device and combination product sector alongside incredible colleagues (Thanks!!!!) —and a successful merge with Kymanox— I decided it was time to embark on a new adventure with the great team at evoleen. Evoleen Access now plays a pivotal role within the Evoleen ecosystem, facilitating market access for both internal and external Digital Health Ventures. Looking forward to discuss any challenges you might have in this area. #MarketAccess #DigitalHealthVentures #Regulatory #medicaldevices
To view or add a comment, sign in
-
#Videofriday #17 Every "Congratulations" message has an impact on us. Some are from Portuguese partners, some from historical partnerships (or recent ones), and others from the other side of the world. Just like the one we show you today, from Wonbum Lee, CEO of Whan In Pharma. Partners with whom we hope to walk side by side for many years. Thank you, again, for your words. You might ask, what are we proud of? Well, you can look it up here: https://bial100years.com #BIAL #BIALKeepingLifeinMind #InspiredByTheFuture
To view or add a comment, sign in
2,409 followers